• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤微环境中的间充质样基质细胞:这些细胞是什么?

Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells?

作者信息

Clavreul Anne, Menei Philippe

机构信息

Département de Neurochirurgie, CHU, 49933 Angers, France.

Université d'Angers, CHU d'Angers, CRCINA, F-49000 Angers, France.

出版信息

Cancers (Basel). 2020 Sep 15;12(9):2628. doi: 10.3390/cancers12092628.

DOI:10.3390/cancers12092628
PMID:32942567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7565954/
Abstract

The glioma microenvironment is a critical regulator of tumor progression. It contains different cellular components such as blood vessels, immune cells, and neuroglial cells. It also contains non-cellular components, such as the extracellular matrix, extracellular vesicles, and cytokines, and has certain physicochemical properties, such as low pH, hypoxia, elevated interstitial pressure, and impaired perfusion. This review focuses on a particular type of cells recently identified in the glioma microenvironment: glioma-associated stromal cells (GASCs). This is just one of a number of names given to these mesenchymal stromal-like cells, which have phenotypic and functional properties similar to those of mesenchymal stem cells and cancer-associated fibroblasts. Their close proximity to blood vessels may provide a permissive environment, facilitating angiogenesis, invasion, and tumor growth. Additional studies are required to characterize these cells further and to analyze their role in tumor resistance and recurrence.

摘要

胶质瘤微环境是肿瘤进展的关键调节因子。它包含不同的细胞成分,如血管、免疫细胞和神经胶质细胞。它还包含非细胞成分,如细胞外基质、细胞外囊泡和细胞因子,并具有某些物理化学特性,如低pH值、缺氧、间质压力升高和灌注受损。本综述重点关注最近在胶质瘤微环境中发现的一种特殊类型的细胞:胶质瘤相关基质细胞(GASC)。这只是赋予这些间充质基质样细胞的众多名称之一,它们具有与间充质干细胞和癌症相关成纤维细胞相似的表型和功能特性。它们与血管的紧密接近可能提供一个有利的环境,促进血管生成、侵袭和肿瘤生长。需要进一步的研究来更全面地描述这些细胞,并分析它们在肿瘤耐药性和复发中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d9/7565954/f481411365c7/cancers-12-02628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d9/7565954/f481411365c7/cancers-12-02628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d9/7565954/f481411365c7/cancers-12-02628-g001.jpg

相似文献

1
Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells?胶质瘤微环境中的间充质样基质细胞:这些细胞是什么?
Cancers (Basel). 2020 Sep 15;12(9):2628. doi: 10.3390/cancers12092628.
2
Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties.胶质母细胞瘤相关基质细胞(GASCs)来源于组织学正常的手术切缘,具有成肌纤维细胞表型和血管生成特性。
J Pathol. 2014 May;233(1):74-88. doi: 10.1002/path.4332. Epub 2014 Feb 20.
3
Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment.胶质瘤相关基质细胞通过调节肿瘤免疫微环境促进胶质瘤恶性进展。
Front Oncol. 2021 Apr 29;11:672928. doi: 10.3389/fonc.2021.672928. eCollection 2021.
4
Rediscovering Potential Molecular Targets for Glioma Therapy Through the Analysis of the Cell of Origin, Microenvironment and Metabolism.通过对起源细胞、微环境和代谢的分析重新发现神经胶质瘤治疗的潜在分子靶点
Curr Cancer Drug Targets. 2021;21(7):558-574. doi: 10.2174/1568009621666210504091722.
5
Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers.肿瘤微环境中的细胞和细胞外成分及其在癌症早期诊断中的应用。
Anal Cell Pathol (Amst). 2020 Jan 8;2020:6283796. doi: 10.1155/2020/6283796. eCollection 2020.
6
Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.二级/三级神经胶质瘤微环境挖掘及其预后价值。
World Neurosurg. 2019 Dec;132:e76-e88. doi: 10.1016/j.wneu.2019.08.253. Epub 2019 Sep 10.
7
Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.癌相关间充质干细胞/基质细胞:致瘤性肿瘤微环境的建筑师。
Stem Cells. 2022 Aug 25;40(8):705-715. doi: 10.1093/stmcls/sxac036.
8
Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment.肿瘤微环境作为黑色素瘤治疗的一个治疗靶点。
Cancers (Basel). 2023 Jun 11;15(12):3147. doi: 10.3390/cancers15123147.
9
How Reciprocal Interactions Between the Tumor Microenvironment and Ion Transport Proteins Drive Cancer Progression.肿瘤微环境与离子转运蛋白之间的相互作用如何驱动癌症进展。
Rev Physiol Biochem Pharmacol. 2022;182:1-38. doi: 10.1007/112_2020_23.
10
CD90 glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.CD90 阳性胶质母细胞瘤间质/干细胞通过激活 FOXS1 介导的上皮间质转化促进胶质母细胞瘤细胞对替莫唑胺耐药。
Stem Cell Res Ther. 2021 Jul 13;12(1):394. doi: 10.1186/s13287-021-02458-8.

引用本文的文献

1
Glioblastoma: Overview of Proteomic Investigations and Biobank Approaches for the Development of a Multidisciplinary Translational Network.胶质母细胞瘤:蛋白质组学研究及生物样本库方法概述,用于构建多学科转化网络
Cancers (Basel). 2025 Jun 26;17(13):2151. doi: 10.3390/cancers17132151.
2
PDCL3 promotes the vasculogenic mimicry of glioma-associated mesenchymal stem cells through VEGFR-2 in glioma environment.在胶质瘤环境中,PDCL3通过VEGFR-2促进胶质瘤相关间充质干细胞的血管生成拟态。
iScience. 2025 Apr 18;28(5):112473. doi: 10.1016/j.isci.2025.112473. eCollection 2025 May 16.
3
Fusion of glioma-associated mesenchymal stem/stromal cells with glioma cells promotes macrophage recruitment and M2 polarization via mA modification of CSF1.

本文引用的文献

1
Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.肿瘤微环境中癌症相关成纤维细胞的结构:解析其起源、异质性及其在癌症治疗耐药中的作用。
OMICS. 2020 Jun;24(6):314-339. doi: 10.1089/omi.2020.0023.
2
Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a/p38/ZEB1 axis.胶质母细胞瘤细胞与间质样干细胞之间的串扰通过 C5a/p38/ZEB1 轴促进胶质母细胞瘤的侵袭性。
Neuro Oncol. 2020 Oct 14;22(10):1452-1462. doi: 10.1093/neuonc/noaa064.
3
Three dimensional in vitro models of cancer: Bioprinting multilineage glioblastoma models.
胶质瘤相关间充质干细胞与胶质瘤细胞的融合通过集落刺激因子1(CSF1)的mA修饰促进巨噬细胞募集和M2极化。
Cell Death Dis. 2025 Apr 26;16(1):345. doi: 10.1038/s41419-025-07678-x.
4
Identification of distinct profiles of glioblastoma through the immunocapture of extracellular vesicles from patient plasma.通过对患者血浆中的细胞外囊泡进行免疫捕获来鉴定胶质母细胞瘤的不同特征。
PLoS One. 2025 Mar 19;20(3):e0315890. doi: 10.1371/journal.pone.0315890. eCollection 2025.
5
Transcriptional landscape of the interaction of human Mesenchymal Stem Cells with Glioblastoma in bioprinted co-cultures.人骨髓间充质干细胞与脑胶质瘤在共培养生物打印中的相互作用的转录组图谱。
Stem Cell Res Ther. 2024 Nov 14;15(1):424. doi: 10.1186/s13287-024-04022-6.
6
Therapeutic approaches to modulate the immune microenvironment in gliomas.调节神经胶质瘤免疫微环境的治疗方法。
NPJ Precis Oncol. 2024 Oct 23;8(1):241. doi: 10.1038/s41698-024-00717-4.
7
Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells.肿瘤治疗电场(TTFields)对人间质基质细胞的影响。
J Neurooncol. 2024 Sep;169(2):329-340. doi: 10.1007/s11060-024-04740-0. Epub 2024 Jun 20.
8
Proteomics of tumor and serum samples from isocitrate dehydrogenase-wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?肿瘤和血清样本的蛋白质组学分析:来自异柠檬酸脱氢酶野生型脑胶质瘤患者的研究——解毒活性氧与较短的生存时间有关吗?
Mol Oncol. 2024 Nov;18(11):2783-2800. doi: 10.1002/1878-0261.13668. Epub 2024 May 27.
9
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.了解胶质瘤的免疫抑制微环境:机制见解和临床观点。
J Hematol Oncol. 2024 May 8;17(1):31. doi: 10.1186/s13045-024-01544-7.
10
Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.关于胶质母细胞瘤瘤周微环境的当前知识
Cancers (Basel). 2023 Nov 17;15(22):5460. doi: 10.3390/cancers15225460.
三维体外癌症模型:生物打印多谱系神经胶质瘤模型。
Adv Biol Regul. 2020 Jan;75:100658. doi: 10.1016/j.jbior.2019.100658. Epub 2019 Oct 17.
4
Glioblastoma Multiforme and Genetic Mutations: The Issue Is Not Over Yet. An Overview of the Current Literature.多形性胶质母细胞瘤与基因突变:问题尚未解决。当前文献综述。
J Neurol Surg A Cent Eur Neurosurg. 2020 Jan;81(1):64-70. doi: 10.1055/s-0039-1688911. Epub 2019 Sep 24.
5
Reversing the Tumor Target: Establishment of a Tumor Trap.逆转肿瘤靶点:构建肿瘤陷阱
Front Pharmacol. 2019 Aug 12;10:887. doi: 10.3389/fphar.2019.00887. eCollection 2019.
6
Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities.间充质干细胞与癌症:临床挑战与机遇。
Biomed Res Int. 2019 May 8;2019:2820853. doi: 10.1155/2019/2820853. eCollection 2019.
7
A new glioblastoma cell trap for implantation after surgical resection.一种新的神经胶质瘤细胞陷阱,用于手术切除后的植入。
Acta Biomater. 2019 Jan 15;84:268-279. doi: 10.1016/j.actbio.2018.11.027. Epub 2018 Nov 19.
8
Tropism of mesenchymal stem cell toward CD133 stem cell of glioblastoma in vitro and promote tumor proliferation in vivo.间质干细胞对胶质母细胞瘤 CD133 干细胞的体外趋化性及其在体内促进肿瘤增殖。
Stem Cell Res Ther. 2018 Nov 9;9(1):310. doi: 10.1186/s13287-018-1049-0.
9
Updates in prognostic markers for gliomas.脑胶质瘤预后标志物的研究进展。
Neuro Oncol. 2018 Nov 9;20(suppl_7):vii17-vii26. doi: 10.1093/neuonc/noy158.
10
CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression.CD90 确定了两种具有不同促肿瘤进展作用的神经胶质瘤相关间充质干细胞亚群。
Cell Death Dis. 2018 Oct 27;9(11):1101. doi: 10.1038/s41419-018-1140-6.